Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Octreotide Acetate for Injection

Approval Number

国药准字H20040639

Company国药集团成都信立邦生物制药有限公司

Registration Date

October 23, 2020

Previous Approval Numbers

国药准字H20040639

Drug Information

Generic Name

注射用醋酸奥曲肽

Trade Name

培新

Brand Name

培新

Dosage Form

注射剂(注射用无菌粉末)

Strength

0.1mg

Drug Type

化学药品

Registration Date

October 23, 2020

Company Information

Applicant Company

Company Name国药集团成都信立邦生物制药有限公司

Company Address

四川省成都市高新技术产业开发区（西区）

Manufacturing Company

Company Name国药集团成都信立邦生物制药有限公司

Company Address

成都高新区西芯大道17号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy